Navigation Links
New data from NIH lab confirms protocol to reverse type 1 diabetes in mice

en cells were the source of at least some of the regenerated islet cell and hastened the restoration of blood sugar levels.

The direct contribution of spleen cells to islet recovery, first described in the 2003 study, is confirmed in the current work. NIH researchers used cell lineage tracking in the form of Y-chromosomal fluorescence in situ hybridization (FISH), in combination with insulin staining, to follow the fate of male spleen cells transplanted into female recipients. The female mice that received male donor cells consistently showed Y-chromosome-positive insulin-producing islet cells, indicating that the introduced spleen cells contribute to islet recovery. The current study also showed that the degree of spleen cell contribution is influenced by mouse age at the start of treatment. Spleen cells appear to contribute to islet recovery more in mice who are older and with more advanced diabetes compared with younger mice with less advanced diabetes, in which regeneration of remaining islets may be the dominant mechanism.


'"/>

Source:Massachusetts General Hospital


Page: 1 2

Related biology news :

1. LUCA technologies confirms real-time methane generation
2. Ancient DNA confirms single origin of Malagasy primates
3. Updated data on novel HPV vaccine confirms efficacy in large population
4. First human study confirms that immune cells can be a primary cause of bone loss in gum disease
5. New method confirms importance of fungi in Arctic nitrogen cycle
6. Genetic surprise confirms neglected 70-year-old evolutionary hypothesis
7. Re-analysis of cigarettes confirms tobacco companies increased addictive nicotine 11 percent
8. Cornell lab confirms deadly fish virus spreading to new species
9. WHO data confirms low level of resistance to Tamiflu
10. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
11. Genetic therapy reverses nervous system damage in animal model of inherited human disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New data from NIH lab confirms protocol reverse type diabetes mice

(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... scientists have developed a technique to create 3-D images that ... mathematician. This technique uses anisotropic triangles triangles with ... to create 3-D "mesh" computer graphics of more accurate approximations ... shorter amount of time than current techniques. These types of ...
... MOUNT VERNON, WA--In the mild coastal climate of western ... of growing popular fresh-market vegetables in high tunnel production ... vegetable crops, including protection from environmental stresses such as ... obvious benefits, the use of high tunnels for growing ...
... 19, 2013  Organovo Holdings, Inc. (NYSE MKT: ONVO) (" Organovo ... bioprinting technology, has been invited to present at the 25th ... New York December 3-4, 2013. ... Murphy , will be presenting on Wednesday, December 4, at ...
Cached Biology News:UT Dallas computer scientists create 3-D technique 2High tunnel, open-field production systems compared for lettuce, tomato 2Organovo to Present at the 25th Annual Piper Jaffray Healthcare Conference 2
(Date:7/31/2015)... ... ... R-Biopharm is proud to announce the RIDASCREEN® Gliadin Competitive ... been accepted by AOAC International as Official First Action method. The AOAC Official ... R5 Competitive ELISA,” based on a specific monoclonal antibody to potentially celiac toxic ...
(Date:7/30/2015)... ... 30, 2015 , ... The 2015 Market Research Report on the Global ... the global Propanol market with a focus on the Chinese situation. Major companies included ... Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua Chemical. , ...
(Date:7/30/2015)...  With over 60,000 customers across the globe, ISN improves the efficiency and effectiveness ... more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In ... Headquartered in Dallas, TX , ISN has additional ...
(Date:7/30/2015)... Bedford, NH (PRWEB) , ... July 30, 2015 ... ... efficiency homogenizer for advanced fluid applications and designed for continuous operation up to ... clean-in-place and sterilization-in-place, ensuring safety, efficiency, and preventing toxic contamination. , The Pony™ ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2
... 27, 2011 Generex Biotechnology Corporation (OTCBB: GNBT) ( ... out of a blog post on Friday, June 24, ... Company,s common stock fell more than 20% and more ... http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b) The author of the blog post ...
... subsidiary of Eisai Inc., announced today that it has successfully ... its employees, more than 5 times as much as it ... number equates to over 40 pounds of food donated per ... through collaboration with Philabundance, the area,s largest food bank and ...
... CRANBURY, N.J., June 27, 2011 Amicus Therapeutics (Nasdaq: ... forefront of developing therapies for rare diseases, today announced ... Russell 3000® and small-cap Russell 2000® Indexes. The Company ... Friday, June 24, 2011, when Russell Investments reconstituted its ...
Cached Biology Technology:Generex Provides Clarification of Facts 2Generex Provides Clarification of Facts 3Generex Provides Clarification of Facts 4Generex Provides Clarification of Facts 5Morphotek, Inc. Employees Collect Nearly 9,000 Pounds of Food for Local Families 2Morphotek, Inc. Employees Collect Nearly 9,000 Pounds of Food for Local Families 3Amicus Therapeutics Joins Russell 3000® Index 2
Practical tool for easy, effective sealing of 0.2ml PCR tubes and plates using cap strips....
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
... Time- and temperature-controlled microwave ... Rehydration and Antigen Retrieval of ... offers ease of use, high ... and high performance. When used ...
... discovery system miniaturizes, integrates and automates ... LabChip technology, the LabChip 3000 performs ... flow fashion. LabChip assays are separations-based, ... what is achievable in homogenous, well-based ...
Biology Products: